IPO registrations (S-1, F-1) · Registrants
PROGENITOR INC
- SEC CIK
- 936537 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1996-06-06, last 1997-08-05; 1 initial registration, 9 amendments
- Outcome
- Final prospectus filed 1997-08-08
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 1507 CHAMBERS RD, Columbus, OH 43212
- EIN
- 31-1344193
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $7.00–$8.00 per share (S-1/A filed 1997-08-05)
- Final price
- $0.01 per share, below the range (424B4 filed 1997-08-08, an initial public offering)
- Shares sold
- 2,750,000
- Gross proceeds
- $27,500 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PGEN
- Lead underwriters
- Lehman Brothers (1,077,500 shares); Genesis Merchant Group Securities (1,077,500 shares)
- Syndicate
- Credit Suisse (60,000); Hambrecht & Quist (60,000); Merrill Lynch (60,000); Montgomery Securities (60,000); Oppenheimer (60,000); Robertson Stephens (60,000); UBS (60,000); Cowen (35,000); Furman Selz LLC (35,000); Pacific Growth Equities, Inc (35,000); Punk, Ziegel & Knoell (35,000); Vector Securities International, Inc (35,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1996-06-06 | S-1 | S-1 (registration) | PROGENITOR INC | 0000912057-96-011748 ↗ |
| 1996-07-11 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-96-014287 ↗ |
| 1996-08-16 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-96-018179 ↗ |
| 1997-03-14 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-008892 ↗ |
| 1997-05-09 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-016309 ↗ |
| 1997-07-03 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-023450 ↗ |
| 1997-07-24 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-024955 ↗ |
| 1997-07-29 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-025215 ↗ |
| 1997-07-29 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-025325 ↗ |
| 1997-08-05 | S-1/A | S-1/A (amendment) | PROGENITOR INC | 0000912057-97-026006 ↗ |
| 1997-08-08 | 424B4 | 424B4 (final prospectus) | PROGENITOR INC | 0000912057-97-026499 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1997-08-05 | S-1/A | registration statement | $7.00–$8.00 | 2,750,000 | - | Nasdaq PGEN | 3 | from the submission text; range, price sentence, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 1997-08-08 | 424B4 | final prospectus | $0.01 | 2,750,000 | $27,500 | Nasdaq PGEN | 14 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 14, cover names 1 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), OH first:
- GLIATECH INC OH
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
- MESOBLAST LTD C3
- Ablynx NV C9
- SANGAMO THERAPEUTICS, INC CA
In other datasets, the same topic (Health) in OH:
- Nonprofit: Adolescent Health Center of Greater (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health